By Aderemi Bunmi Kutelu

Breast cancer remains one of the most significant public health challenges in the world, affecting hundreds of thousands of women and their families each year. While advances in medical research and technology have improved early detection and treatment, critical gaps persist in medication adherence, equitable access to treatment, and patient education—particularly in underserved communities. As a pharmacist and public health advocate, my work focuses on enhancing access to pharmaceuticals, optimizing medication adherence, and improving patient outcomes for breast cancer patients across the globe. Through pharmacist-led interventions, strategic public health collaborations, and innovative medication management programs, I have addressed the pressing need for a more inclusive, accessible, and patient-centered approach to breast cancer treatment. Breast cancer remains one of the most significant public health challenges in Nigeria, affecting hundreds of thousands of women and their families each year. While advances in medical research and technology have improved early detection and treatment, critical gaps persist in medication adherence, equitable access to treatment, and patient education—particularly in underserved communities. As a pharmacist and public health advocate, my work focuses on enhancing access to pharmaceuticals, optimizing medication adherence, and improving patient outcomes for breast cancer patients nationwide. Through pharmacist-led interventions, strategic public health collaborations, and innovative medication management programs, I strive to address the pressing need for a more inclusive, accessible, and patient-centered approach to breast cancer treatment.

The Urgent Need for Pharmacist-Led Breast Cancer Interventions

Breast cancer is the most commonly diagnosed cancer among women in the United States. In 2024, an estimated 310,720 new cases of invasive breast cancer will be diagnosed, contributing to a significant public health and economic burden. (cancer.org)

Despite the availability of life-saving treatments, research shows that 33% of women with metastatic breast cancer struggle with medication adherence (pmc.ncbi.nlm.nih.gov). Medication nonadherence—whether due to cost, side effects, or lack of education—significantly reduces survival rates and leads to higher recurrence rates.

Moreover, minority and low-income populations face additional barriers to care. Studies indicate that Black, Native, and Asian American women are more likely to decline breast cancer treatment due to medical mistrust and socioeconomic factors (verywellhealth.com). These disparities underscore the urgent need for community-based pharmacist interventions that improve treatment adherence and patient education.

Pharmacists as Key Players in Breast Cancer Treatment

Pharmacists are often underutilized in cancer treatment strategies, yet they play a crucial role in medication safety, adherence, and patient counseling. Studies have shown that pharmacist-led medication therapy management (MTM) programs improve treatment compliance and reduce adverse drug reactions, leading to better health outcomes.

A key component of my endeavor is to integrate pharmacist-driven interventions into oncology care teams, community health programs, and national public health initiatives. This includes:

1. Medication Adherence Programs: Developing pharmacist-led patient counseling sessions to ensure that breast cancer patients understand the importance of medication adherence and receive support for managing side effects.
2. Public Health Education & Awareness: Collaborating with government agencies, nonprofit organizations, and community pharmacies to increase awareness of breast cancer treatment options and promote early screening initiatives.
3. Pharmaceutical Access & Affordability: Working alongside healthcare policymakers and advocacy groups to expand insurance coverage and medication affordability programs, ensuring that breast cancer treatments remain accessible to all.
4. Research & Policy Advocacy: Supporting data-driven pharmaceutical research to improve drug efficacy, optimize treatment protocols, and influence policy decisions at the national level.

A Call to Action: Expanding Pharmacist-Led Solutions in Breast Cancer Care

To achieve lasting change in breast cancer treatment adherence and healthcare accessibility, we must:

1. Expand the Role of Pharmacists in Oncology Teams: Pharmacists must be recognized as essential members of multidisciplinary cancer treatment teams, ensuring patients receive comprehensive medication counseling and adherence support.
2. Increase Funding for Pharmacist-Led Public Health Programs: Federal and state governments should invest in community pharmacy initiatives that address medication adherence challenges for breast cancer patients.
3. Enhance Collaboration Between Healthcare Providers and Pharmacists: Hospitals, research institutions, and public health organizations must work together to develop integrated pharmaceutical care models that optimize breast cancer treatment outcomes.
4. Strengthen Public Awareness Campaigns on Medication Adherence: Educational outreach programs should be expanded to empower breast cancer patients with knowledge and resources to manage their treatments effectively.

Breast cancer treatment is not just about medical breakthroughs, it’s about ensuring that patients can access, afford, and follow these life-saving treatments. Pharmacists play a crucial role in bridging this gap, and my proposed initiative aims to bring innovative, pharmacist-led solutions to the forefront of national cancer care efforts. 

By utilizing medication adherence programs, public health education, pharmaceutical research, and policy advocacy, we can improve breast cancer survival rates, reduce healthcare disparities, and empower patients across the country. The time to act is now—because every missed dose, delayed treatment, or unaddressed barrier to care can mean the difference between life and death.

Aderemi Bunmi Kutelu is a
Pharmacist, Public Health Advocate and Medication Adherence Specialist.